Log in
【粤开医药行业月报】看好消费医疗业绩修复和创新药高成长性-20230601-粤开证券-23页
English body is not available for this report yet; showing the Chinese version. View in Chinese
常见问题
- 这份报告主要研究什么？
- 《【粤开医药行业月报】看好消费医疗业绩修复和创新药高成长性-202306…》主要讨论：行情回顾 5月医药生物指数收跌2.50%，位列申万31个子行业第10位，跑赢沪深300指数3.22个百分点。年初以来，医药生物累计下跌1.12%，位列申万31个子行业第15位，跑赢沪深 300 指数…
- 报告来自哪个机构？何时发布？
- 来源机构：粤开证券，报告发布于 2023-06-01，篇幅约 23 页。
Copyright notice
This report is aggregated from publicly available internet sources. Copyright belongs to the original authors or rights holders. If you are a rights holder and believe content on this platform infringes your rights, please email copyright@ruishubaogao.com . We will remove the content promptly after verification.